PCR fluorescence

PCR manawa maoli Multiplex | ʻenehana piʻo hoʻoheheʻe | Pololei | ʻŌnaehana UNG | Reagent wai a me ka lyophilized

PCR fluorescence

  • 12 ʻAno o ka maʻi hanu

    12 ʻAno o ka maʻi hanu

    Hoʻohana ʻia kēia kit no ka hui ʻana o ka qualitative detection o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae, rhinovirus, respiratory syncytial virus a me parainfluenza virus (Ⅰ, II, III, IV) a me metapneumovirus kanaka i loko o nā swabs oropharyngeal..

  • Ka maʻi Hepatitis E

    Ka maʻi Hepatitis E

    He kūpono kēia pahu hana no ka ʻike qualitative o ka maʻi hepatitis E (HEV) nucleic acid i loko o nā laʻana serum a me nā laʻana ʻōpala in vitro.

  • Ka maʻi Hepatitis A

    Ka maʻi Hepatitis A

    He kūpono kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic o ka maʻi hepatitis A (HAV) i loko o nā laʻana serum a me nā laʻana ʻōpala in vitro.

  • ʻO ka fluorescence helu DNA o ka maʻi Hepatitis B

    ʻO ka fluorescence helu DNA o ka maʻi Hepatitis B

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka nui o ka waikawa nucleic o ka maʻi hepatitis B i loko o nā laʻana serum kanaka a i ʻole plasma.

  • HPV16 a me HPV18

    HPV16 a me HPV18

    ʻAʻohe kēia pahu hanani hoʻolaʻa ʻia no ka ʻike qualitative in vitro o nā ʻāpana nucleic acid kikoʻī o ka human papillomavirus (HPV) 16 a me HPV18 i loko o nā pūnaewele exfoliated cervical wahine.

  • ʻO Mycoplasma Genitalium (Mg) Mea ʻImi ʻAka Nucleic

    ʻO Mycoplasma Genitalium (Mg) Mea ʻImi ʻAka Nucleic

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o ka Mycoplasma genitalium (Mg) nucleic acid i loko o ke ala mimi kāne a me nā mea huna o ke ala genital wahine.

  • ʻO ka maʻi Dengue, ka maʻi Zika a me ka maʻi Chikungunya Multiplex

    ʻO ka maʻi Dengue, ka maʻi Zika a me ka maʻi Chikungunya Multiplex

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi dengue, ka maʻi Zika a me nā waikawa nucleic o ka maʻi chikungunya i loko o nā hāpana serum.

  • Ka Hoʻololi ʻana o ke Kine Hoʻohui TEL-AML1 Kanaka

    Ka Hoʻololi ʻana o ke Kine Hoʻohui TEL-AML1 Kanaka

    Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka TEL-AML1 fusion gene i loko o nā hāpana iwi kanaka in vitro.

  • 17 ʻAno o ka Human Papillomavirus (16/18/6/11/44 Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    17 ʻAno o ka Human Papillomavirus (16/18/6/11/44 Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    Kōmike Huahana

    HWTS-CC015

    ʻAe ʻia ka huahana

    CE, Vietnam MDA

    He kūpono kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o 17 mau ʻano o ka human papillomavirus (HPV 6, 11, 16, 18, 31, 33, 35, 39, 44, 45, 51, 52, 56, 58, 59, 66, 68) nā ʻāpana nucleic acid kikoʻī i loko o ka laʻana mimi, ka laʻana swab cervical wahine a me ka laʻana swab vaginal wahine, a me ka ʻike ʻana i ke ʻano HPV 16/18/6/11/44 e kōkua i ka ʻike a me ka mālama ʻana i ka maʻi HPV.

  • ʻO ka waikawa nukleika Borrelia Burgdorferi

    ʻO ka waikawa nukleika Borrelia Burgdorferi

    He kūpono kēia huahana no ka ʻike qualitative in vitro o ka Borrelia burgdorferi nucleic acid i loko o ke koko holoʻokoʻa o nā maʻi, a hāʻawi i nā mea kōkua no ka ʻike ʻana i nā maʻi Borrelia burgdorferi.

  • Ka Hoʻololi ʻana o ka Mycobacterium Tuberculosis INH

    Ka Hoʻololi ʻana o ka Mycobacterium Tuberculosis INH

    He kūpono kēia pahu no ka ʻike ʻana i nā wahi mutation nui i nā laʻana sputum kanaka i hōʻiliʻili ʻia mai nā poʻe maʻi Tubercle bacillus maikaʻi e alakaʻi ai i ka mycobacterium tuberculosis INH: ʻĀpana hoʻolaha InhA -15C>T, -8T>A, -8T>C; ʻĀpana hoʻolaha AhpC -12C>T, -6G>A; mutation homozygous o KatG 315 codon 315G>A, 315G>C.

  • Ka maʻi Zika

    Ka maʻi Zika

    Hoʻohana ʻia kēia pahu hana e ʻike pono i ka Zika virus nucleic acid i loko o nā hāpana serum o nā poʻe maʻi i manaʻo ʻia he maʻi Zika ma vitro.